Skip to content

Released Aug 8, 2023, after the close

10-Q filed Aug 9, 2023, 40 days after period end · 0001636422-23-000096

Q2 2023 · 10-Q
Revenue$73.21M+3.7% vs Q2 2022−0.9% vs Q1 2023
Net Income-$32.61MN/M vs Q2 2022N/M vs Q1 2023
EPS Diluted-$0.58N/M vs Q2 2022N/M vs Q1 2023
Operating Income-$34,618,000N/M
Operating Cash Flowderived-$11,574,000N/M
Free Cash Flowderived-$11,981,000N/M
Margins · derived
Operating margin-47.3%−0.3 pt vs Q2 2022
Net margin-44.5%+2.8 pt vs Q2 2022

What the release said

The release

Same quarter

MetricQ2 2023Q2 2022Q2 2021Q2 2020
Revenue$73.21M$70.63M$59.63M$43.26M
Net Income-$32.61M-$33.43M-$35.83M-$27.18M
EPS Diluted-$0.58-$0.62-$0.80-$0.71

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Health Catalyst, Inc. · CIK 1636422 · Engraved from SEC EDGAR